Primer probe group and kit for combined detection of mycoplasma pneumoniae and chlamydia pneumoniae based on fluorescence RMA method

A technology of mycoplasma pneumoniae and chlamydia pneumoniae, applied in the direction of microorganism-based methods, DNA/RNA fragments, microorganisms, etc., can solve the problems of easy pollution, poor sensitivity, multiple false positive results, etc., to avoid false positives and environmental pollution, Reduce reaction time and temperature, avoid cross-reaction effects

Pending Publication Date: 2021-04-02
济南国益生物科技有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, the commonly used detection methods for Mycoplasma pneumoniae and Chlamydia pneumoniae are as follows: (1) Virus isolation and culture method: It is the most reliable method for diagnosing MP and Cpn infection, but so far, these two pathogens are difficult to obtain through culture, On the one hand, because most of these patients have dry cough, it is difficult to obtain sputum samples; on the other hand, the culture requirements for mycoplasma and chlamydia are very high, and it is difficult for general laboratories
(2) Serological detection: The most commonly used serological method is complement fixation reaction (CFTs), but there are many shortcomings in this method, such as the false positive of mycoplasma CFTs can appear in the inflammatory reaction process, and CFTs cannot be used to distinguish C

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer probe group and kit for combined detection of mycoplasma pneumoniae and chlamydia pneumoniae based on fluorescence RMA method
  • Primer probe group and kit for combined detection of mycoplasma pneumoniae and chlamydia pneumoniae based on fluorescence RMA method
  • Primer probe group and kit for combined detection of mycoplasma pneumoniae and chlamydia pneumoniae based on fluorescence RMA method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] 1. Preparation of positive standard plasmid

[0046] The RNA of MP and Cpn was extracted as a template, and the adhesion protein P1 gene of MP and the outer membrane protein A gene of Cpn were amplified by PCR. The PCR amplification products were subjected to 1% agarose gel electrophoresis, recovered by tapping gel, and cloned into pMD18 -T vector, transformed into Escherichia coli competent cells, blue-white screening, picking white colonies, and colony PCR verification. Send the positive recombinant bacteria to the company for sequencing, culture the correctly sequenced recombinant bacteria overnight, extract plasmid DNA, and obtain positive plasmids (P-MP, P-Cpn).

[0047] 2. Design of fluorescent RMA primers and probes

[0048] Fluorescent RMA primers and probes were designed for the adhesion protein P1 gene of MP and the outer membrane protein A gene of Cpn, as shown in Table 2:

[0049] Table 2 Primer and Probe Sequences

[0050]

[0051] Note: The fluoresce...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of detection of mycoplasma pneumoniae and chlamydia pneumoniae, and particularly relates to a primer probe group, a kit and a detection method for combineddetection of mycoplasma pneumoniae and chlamydia pneumoniae based on a fluorescence RMA method. The kit comprises a detection tube containing an amplification reaction reagent, a buffer solution, magnesium acetate, standard positive plasmids and sterile double distilled water. The amplification reaction reagent is prepared from primers and probes of MP and Cpn, M-MLV reverse transcriptase, escherichia coli RecA protein, UvsY protein, single-stranded binding protein GP32, Bst polymerase, exonuclease III, polyethylene oxide, trehalose, mannitol, ATP, dNTPs, creatine kinase and creatine phosphate. The standard positive plasmids are recombinant plasmids containing MP and Cpn amplified gene sequences, and are used for positive control of MP and Cpn nucleic acid detection.

Description

technical field [0001] The application belongs to the technical field of detection of Mycoplasma pneumoniae and Chlamydia pneumoniae, and specifically relates to a primer-probe set, a kit and a detection method for combined detection of Mycoplasma pneumoniae and Chlamydia pneumoniae based on a fluorescent RMA method. Background technique [0002] Mycoplasma pneumoniae (MP) is one of the important pathogens of community-acquired pneumonia (CAP) in children. Mycoplasma pneumoniae is a microorganism between bacteria and viruses. It is mainly transmitted through the respiratory tract. Mycoplasma can spread to any organ in the body through blood. In addition, mycoplasma infection can produce autoantibodies, resulting in multi-system immune damage, causing multiple The system is malfunctioning. Mycoplasma pneumoniae pneumonia (MPP) accounts for 10%-40% of CAP in hospitalized children and is a widespread concern for pediatricians. [0003] Chlamydia pneumoniae (Cpn) is an obligat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/689C12Q1/6844C12Q1/04C12N15/11C12R1/35C12R1/01
CPCC12Q1/689C12Q1/6844
Inventor 刘建生包建民陈大为陈龙张瑶
Owner 济南国益生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products